Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Pharmacology ; 105(9-10): 568-575, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31940650

RESUMEN

BACKGROUND: To study the protective effects of ganoderic acid A (GAA) on bleomycin (BLM)-induced pulmonary fibrosis. METHODS: ICR mice were intratracheally instilled with BLM to induce pulmonary fibrosis on day 0. Then the mice were orally given GAA (25, 50 mg/kg) or dexamethasone (2 mg/kg). After treatment for 21 days, the mice were sacrificed. Wet dry weight (W/D) ratio of lung was used to detect pulmonary edema. Myeloperoxidase (MPO), interleukin-1ß (IL-1ß), IL-6, tumor necrosis factor-α (TNF-α), malondialdehyde (MDA), and superoxide dismutase (SOD) were detected by enzyme-linked immunosorbent assay. Hematoxylin and eosin staining was used to evaluate the pathological changes. The levels of transforming growth factor ß (TGF-ß), phosphorylated-smad3 (p-smad3), p-IκB, and p-nuclear factor-kappa B (NF-κB) in lung tissue were detected by western blot. RESULTS: GAA treatment significantly improved MPO activity, W/D ratio, and lung histopathology. The protective effect of GAA may be related to downregulation of TNF-α, IL-1ß, IL-6, MDA and upregulation of SOD. In addition, GAA significantly decreased the levels of TGF-ß, p-smad3, p-IκB, and p-NF-κB, compared with those in BLM group. CONCLUSION: GAA has protective effect on BLM-induced lung injury, and TGF-ß/Smad-3/NF-κB signaling pathway may play an important role in the pathogenesis of BLM-induced lung injury.


Asunto(s)
Ácidos Heptanoicos/farmacología , Lanosterol/análogos & derivados , Pulmón/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Fibrosis Pulmonar/tratamiento farmacológico , Animales , Bleomicina/toxicidad , Citocinas/sangre , Ácidos Heptanoicos/uso terapéutico , Lanosterol/farmacología , Lanosterol/uso terapéutico , Pulmón/metabolismo , Pulmón/patología , Masculino , Malondialdehído/sangre , Ratones , Ratones Endogámicos ICR , FN-kappa B/metabolismo , Peroxidasa/metabolismo , Fitoterapia , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Sustancias Protectoras/uso terapéutico , Edema Pulmonar/tratamiento farmacológico , Fibrosis Pulmonar/inducido químicamente , Proteína smad3/metabolismo , Superóxido Dismutasa/sangre , Factor de Crecimiento Transformador beta/metabolismo
2.
J Ethnopharmacol ; 146(1): 372-8, 2013 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-23318412

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: The pericarp of Citrus reticulata possesses medical functions of regulating Qi and expelling phlegm, and has been clinically used for the treatment of lung related diseases in traditional Chinese medicine for a long time. Our previous research revealed that Citrus reticulata exhibited inhibitory effects on pulmonary fibrosis; however, its active principles are still unclear. AIM OF THE STUDY: To investigate the inhibitory effects on pulmonary fibrosis of alkaline extract from ethanol extract of Citrus reticulata and clarify its possible mechanism. MATERIALS AND METHODS: The citrus alkaline extract (CAE) was prepared from ethanol extract of Citrus reticulata and MRC-5 cells were used for the evaluation of inhibitory activity in vitro. CAE was further orally administrated to bleomycin (BLM)-induced pulmonary fibrosis rats. The rat body weight, hydroxyproline levels in serum and lung, pathological changes of lung, as well as mRNA and protein expressions of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1) and tumor necrosis factor-α (TNF-α) in rat lung tissues were analyzed. RESULTS: CAE dose-dependently inhibited the proliferation of MRC-5 cells, and the LDH assay clearly revealed that the inhibitory activity of CAE was not due to its cytotoxicity. CAE treatment significantly increased rat weight gain, ameliorated alveolitis and pulmonary fibrosis degree, and lowered hydroxyproline contents in both serum and lung tissues. RT-PCR and western blot revealed that mRNA and protein expressions of MMP-9 were significantly elevated, while mRNA and protein levels of TIMP-1 and TNF-α were markedly decreased in lung tissues of CAE treated rats. CONCLUSIONS: The results collectively demonstrated that CAE possessed an inhibitory activity on the proliferation of MRC-5 and a preventive effect on BLM-induced pulmonary fibrosis in rats. The preliminary mechanisms of the effects may be through upregulation of MMP-9 expression and inhibition of the expressions of TNF-α and TIMP-1.


Asunto(s)
Antiinflamatorios/uso terapéutico , Citrus , Extractos Vegetales/uso terapéutico , Fibrosis Pulmonar/tratamiento farmacológico , Animales , Antiinflamatorios/farmacología , Bleomicina , Línea Celular , Proliferación Celular/efectos de los fármacos , Humanos , Hidroxiprolina/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Masculino , Metaloproteinasa 9 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/metabolismo , Fitoterapia , Extractos Vegetales/farmacología , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Inhibidor Tisular de Metaloproteinasa-1/genética , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...